dilmapimod   Click here for help

GtoPdb Ligand ID: 7815

Synonyms: SB-681323
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This is Example 64 in patent EP1333833 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 99.75
Molecular weight 456.14
XLogP 4.06
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC(Nc1nc(c2ccc(cc2C)F)c2c(n1)n(c(=O)cc2)c1c(F)cccc1F)CO
Isomeric SMILES OCC(Nc1nc(c2ccc(cc2C)F)c2c(n1)n(c(=O)cc2)c1c(F)cccc1F)CO
InChI InChI=1S/C23H19F3N4O3/c1-12-9-13(24)5-6-15(12)20-16-7-8-19(33)30(21-17(25)3-2-4-18(21)26)22(16)29-23(28-20)27-14(10-31)11-32/h2-9,14,31-32H,10-11H2,1H3,(H,27,28,29)
InChI Key ORVNHOYNEHYKJG-UHFFFAOYSA-N
References
1. Adams JL, Boehm JC, Hall R, Jin Q, Kasparec J, Silva DJ, Taggart JJ. 
Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases.
Patent number: EP1333833. Assignee: GlaxoSmithKline LLC. Priority date: 23/10/2000. Publication date: 23/10/2001.